mission critical appointment ex medtronics

http://finance.yahoo.com/news/sunshine-heart-appoints-kimberly-oleson-093000097.html

Sunshine Heart, Inc. (SSH) today announced the appointment of Kimberly Oleson to the post of Senior Vice President, Clinical Affairs. In this capacity, Ms. Oleson will manage all aspects of the Company's US pivotal study (COUNTER HF(TM)) and EU post-market study (OPTIONS HF) for its flagship C-Pulse(R) Heart Assist System, a medical device addressing Class III and ambulatory Class IV heart failure.

"Kim brings to the Company deep expertise across all aspects of medical device trial enrollment and management. Having been involved with over 400 clinical trials in her career, it is a pleasure to welcome someone of Kim's caliber to the Company and is a testament to the potential role the C-Pulse System will play in the treatment landscape for heart failure patients," said Dave Rosa, Chief Executive Officer of Sunshine Heart.

Prior to joining Sunshine Heart, Ms. Oleson was Vice President of Global Clinical Operations at Medtronic, Inc. (MDT), one of the world's largest medical technology companies where she was the strategist responsible for building the company's first centralized clinical operations organization serving Medtronic's broad portfolio of clinical trials and developing contemporary methods related to total product lifecycle risk management and clinical trial risk management. Trained as a biostatistician, Ms. Oleson's distinguished career includes positions of increasing responsibility across large and venture-based businesses within Medtronic, resulting in the global commercial release of multiple medical therapies in the fields of cardiology, interventional cardiology, cardiac electrophysiology, neurology and drug delivery. In addition to her clinical trial expertise, Ms. Oleson has co-authored 10 peer-reviewed publications and is credited with 4 issued/filed patents. She is an industry representative for regulatory standard technical committees including the International Standards Organization which published the ISO 14155:2011 Good Clinical Practice standard for medical device clinical trials. Ms. Oleson holds a B.A. in Biometry from the University of Minnesota.

SSH continues to take its pick of very high standard people.
Would of thought she was mission critical for Medtronics?
Why has she come across from a mega company to a minnow of an industry startup?
Medtronic was always our favourite as the strategic investor.
Are they getting sick of waiting?